H.Con.Res. 35 · 119th Congress · Congress
Exposing Congressional Drug Abuse Act
- IntroducedJun 5, 2025 Done
- CommitteeReferred to House Administration Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
What it does
The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.Who lobbies on it
No lobbying filing on file names H.Con.Res. 35.
Organizations that named H.Con.Res. 35 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Jun 5, 2025Referred to the House Committee on House Administration.
- Jun 5, 2025Submitted in House
What members said about it
-
Higgins Reintroduces Legislation to Drug Test Congress
Congressman Clay Higgins (R-LA) reintroduced H.Con.Res. 35, the Exposing Congressional Drug Abuse Act, which requires members of the U.S. House of Representatives and U.S. Senate to participate in random drug screenings.
“Elected officials in Washington, D.C. should be subject to the same kind of random drug screenings that every blue-collar, working-class American endures.”